Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes

José H. Volders, Vera L. Negenborn, Pauline E. Spronk, Nicole M.A. Krekel, Linda J. Schoonmade, Sybren Meijer, Isabel T. Rubio, M. Petrousjka van Den Tol

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Purpose: Neoadjuvant chemotherapy (NACT) is increasingly used in breast cancer treatment. One of the main goals of NACT is to reduce the extent of local surgery of the breast and axilla. The aim of this study was to determine surgical outcomes for patients receiving breast-conserving therapy (BCT) after NACT, including margin status plus secondary surgeries, excision volumes, and cosmetic outcomes. Methods: A systematic review was performed in accordance with PRISMA principles. Pubmed, MEDLINE, Embase, and the Cochrane Library were searched for studies investigating the results of BCT following NACT. The main study outcomes were margin status, additional local therapies, excision volumes, and cosmetic outcomes. Non-comparative studies on NACT were also included. Exclusion criteria were studies with less than 25 patients, and studies excluding secondary mastectomy patients. Findings: Of the 1219 studies screened, 26 studies were deemed eligible for analysis, including data from 5379 patients treated with NACT and 10,110 patients treated without NACT. Included studies showed wide ranges of tumor-involved margins (2–39.8%), secondary surgeries (0–45.4%), and excision volumes (43.2–268 cm3) or specimen weight (26.4–233 g) after NACT. Most studies were retrospective, with a high heterogeneity and a high risk of bias. Cosmetic outcomes after NACT were reported in two single-center cohort studies. Both studies showed acceptable cosmetic outcomes. Interpretation: There is currently insufficient evidence to suggest that NACT improves surgical outcomes of BCT. It is imperative that clinical trials include patient outcome measures in order to allow monitoring and meaningful comparison of treatment outcomes in breast cancer.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalBreast Cancer Research and Treatment
Volume168
Issue number1
DOIs
Publication statusPublished - 1 Feb 2018

Cite this

Volders, José H. ; Negenborn, Vera L. ; Spronk, Pauline E. ; Krekel, Nicole M.A. ; Schoonmade, Linda J. ; Meijer, Sybren ; Rubio, Isabel T. ; van Den Tol, M. Petrousjka. / Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes. In: Breast Cancer Research and Treatment. 2018 ; Vol. 168, No. 1. pp. 1-11.
@article{f816dc11cecf46cd8c62d2e758ac301a,
title = "Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes",
abstract = "Purpose: Neoadjuvant chemotherapy (NACT) is increasingly used in breast cancer treatment. One of the main goals of NACT is to reduce the extent of local surgery of the breast and axilla. The aim of this study was to determine surgical outcomes for patients receiving breast-conserving therapy (BCT) after NACT, including margin status plus secondary surgeries, excision volumes, and cosmetic outcomes. Methods: A systematic review was performed in accordance with PRISMA principles. Pubmed, MEDLINE, Embase, and the Cochrane Library were searched for studies investigating the results of BCT following NACT. The main study outcomes were margin status, additional local therapies, excision volumes, and cosmetic outcomes. Non-comparative studies on NACT were also included. Exclusion criteria were studies with less than 25 patients, and studies excluding secondary mastectomy patients. Findings: Of the 1219 studies screened, 26 studies were deemed eligible for analysis, including data from 5379 patients treated with NACT and 10,110 patients treated without NACT. Included studies showed wide ranges of tumor-involved margins (2–39.8{\%}), secondary surgeries (0–45.4{\%}), and excision volumes (43.2–268 cm3) or specimen weight (26.4–233 g) after NACT. Most studies were retrospective, with a high heterogeneity and a high risk of bias. Cosmetic outcomes after NACT were reported in two single-center cohort studies. Both studies showed acceptable cosmetic outcomes. Interpretation: There is currently insufficient evidence to suggest that NACT improves surgical outcomes of BCT. It is imperative that clinical trials include patient outcome measures in order to allow monitoring and meaningful comparison of treatment outcomes in breast cancer.",
keywords = "Breast-conserving therapy, Cosmetic outcome, Excision volume, Margins, Neoadjuvant chemotherapy, Secondary mastectomy",
author = "Volders, {Jos{\'e} H.} and Negenborn, {Vera L.} and Spronk, {Pauline E.} and Krekel, {Nicole M.A.} and Schoonmade, {Linda J.} and Sybren Meijer and Rubio, {Isabel T.} and {van Den Tol}, {M. Petrousjka}",
year = "2018",
month = "2",
day = "1",
doi = "10.1007/s10549-017-4598-5",
language = "English",
volume = "168",
pages = "1--11",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes. / Volders, José H.; Negenborn, Vera L.; Spronk, Pauline E.; Krekel, Nicole M.A.; Schoonmade, Linda J.; Meijer, Sybren; Rubio, Isabel T.; van Den Tol, M. Petrousjka.

In: Breast Cancer Research and Treatment, Vol. 168, No. 1, 01.02.2018, p. 1-11.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes

AU - Volders, José H.

AU - Negenborn, Vera L.

AU - Spronk, Pauline E.

AU - Krekel, Nicole M.A.

AU - Schoonmade, Linda J.

AU - Meijer, Sybren

AU - Rubio, Isabel T.

AU - van Den Tol, M. Petrousjka

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Purpose: Neoadjuvant chemotherapy (NACT) is increasingly used in breast cancer treatment. One of the main goals of NACT is to reduce the extent of local surgery of the breast and axilla. The aim of this study was to determine surgical outcomes for patients receiving breast-conserving therapy (BCT) after NACT, including margin status plus secondary surgeries, excision volumes, and cosmetic outcomes. Methods: A systematic review was performed in accordance with PRISMA principles. Pubmed, MEDLINE, Embase, and the Cochrane Library were searched for studies investigating the results of BCT following NACT. The main study outcomes were margin status, additional local therapies, excision volumes, and cosmetic outcomes. Non-comparative studies on NACT were also included. Exclusion criteria were studies with less than 25 patients, and studies excluding secondary mastectomy patients. Findings: Of the 1219 studies screened, 26 studies were deemed eligible for analysis, including data from 5379 patients treated with NACT and 10,110 patients treated without NACT. Included studies showed wide ranges of tumor-involved margins (2–39.8%), secondary surgeries (0–45.4%), and excision volumes (43.2–268 cm3) or specimen weight (26.4–233 g) after NACT. Most studies were retrospective, with a high heterogeneity and a high risk of bias. Cosmetic outcomes after NACT were reported in two single-center cohort studies. Both studies showed acceptable cosmetic outcomes. Interpretation: There is currently insufficient evidence to suggest that NACT improves surgical outcomes of BCT. It is imperative that clinical trials include patient outcome measures in order to allow monitoring and meaningful comparison of treatment outcomes in breast cancer.

AB - Purpose: Neoadjuvant chemotherapy (NACT) is increasingly used in breast cancer treatment. One of the main goals of NACT is to reduce the extent of local surgery of the breast and axilla. The aim of this study was to determine surgical outcomes for patients receiving breast-conserving therapy (BCT) after NACT, including margin status plus secondary surgeries, excision volumes, and cosmetic outcomes. Methods: A systematic review was performed in accordance with PRISMA principles. Pubmed, MEDLINE, Embase, and the Cochrane Library were searched for studies investigating the results of BCT following NACT. The main study outcomes were margin status, additional local therapies, excision volumes, and cosmetic outcomes. Non-comparative studies on NACT were also included. Exclusion criteria were studies with less than 25 patients, and studies excluding secondary mastectomy patients. Findings: Of the 1219 studies screened, 26 studies were deemed eligible for analysis, including data from 5379 patients treated with NACT and 10,110 patients treated without NACT. Included studies showed wide ranges of tumor-involved margins (2–39.8%), secondary surgeries (0–45.4%), and excision volumes (43.2–268 cm3) or specimen weight (26.4–233 g) after NACT. Most studies were retrospective, with a high heterogeneity and a high risk of bias. Cosmetic outcomes after NACT were reported in two single-center cohort studies. Both studies showed acceptable cosmetic outcomes. Interpretation: There is currently insufficient evidence to suggest that NACT improves surgical outcomes of BCT. It is imperative that clinical trials include patient outcome measures in order to allow monitoring and meaningful comparison of treatment outcomes in breast cancer.

KW - Breast-conserving therapy

KW - Cosmetic outcome

KW - Excision volume

KW - Margins

KW - Neoadjuvant chemotherapy

KW - Secondary mastectomy

UR - http://www.scopus.com/inward/record.url?scp=85037166999&partnerID=8YFLogxK

U2 - 10.1007/s10549-017-4598-5

DO - 10.1007/s10549-017-4598-5

M3 - Article

VL - 168

SP - 1

EP - 11

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -